Moreover, it has been reported that PI3K-mTOR inhibition does not promote substantial apoptosis in the EGFR mutant lung cancer while it induced apoptosis in HER2-amplified breast cancer (11). The gene discussed is MTOR; the disease is breast carcinoma.